Goenka A, Tiek D, Song X, Huang T, Hu B, Cheng SY. The many facets of Therapy Resistance and Tumor Recurrence in Glioblastoma. CELLS-BASEL 2021, 10(3).

Groenendijk A, Spreafico F, de Krijger RR, Drost J, Brok J, Perotti D, van Tinteren H, Venkatramani R, Godzinski J, Rube C et al. Prognostic Factors for Wilms Tumor Recurrence: A Review of the Literature. CANCERS 2021, 13(13).

Li Y, Ma Y, Wu Z, Xie R, Zeng F, Cai H, Lui S, Song B, Chen L, Wu M. Advanced Imaging techniques for differentiating pseudoprogression and Tumor Recurrence after Immunotherapy for Glioblastoma. FRONT IMMUNOL. 2021;12:790674.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hamdy FC, Donovan JL, Lane JA, Metcalfe C, Davis M, Turner EL, Martin RM, Young GJ, Walsh EI, Bryant RJ, et al. Fifteen-year outcomes after monitoring, Surgery, or Radiotherapy for Prostate Cancer. NEW ENGL J MED. 2023;388(17):1547–58.

Article  PubMed  Google Scholar 

Lin D, Shen L, Luo M, Zhang K, Li J, Yang Q, Zhu F, Zhou D, Zheng S, Chen Y, et al. Circulating Tumor cells: biology and clinical significance. SIGNAL TRANSDUCT TAR. 2021;6(1):404.

Article  CAS  Google Scholar 

Chang MC, Chang YT, Chen JY, Jeng YM, Yang CY, Tien YW, Yang SH, Chen HL, Liang TY, Wang CF, et al. Clinical significance of circulating Tumor Microemboli as a prognostic marker in patients with pancreatic ductal adenocarcinoma. CLIN CHEM. 2016;62(3):505–13.

Article  CAS  PubMed  Google Scholar 

Tao J, Zhu L, Yakoub M, Reissfelder C, Loges S, Scholch S. Cell-cell interactions drive Metastasis of circulating Tumor Microemboli. CANCER RES. 2022;82(15):2661–71.

Article  CAS  PubMed  Google Scholar 

Jiang L, Yang H, Cheng W, Ni Z, Xiang N. Droplet microfluidics for CTC-based liquid biopsy: a review. ANALYST. 2023;148(2):203–21.

Article  CAS  PubMed  Google Scholar 

Chauhan A, Kaur R, Ghoshal S, Pal A. Exploration of circulating Tumour Cell (CTC) Biology: a paradigm shift in Liquid Biopsy. INDIAN J CLIN BIOCHE. 2021;36(2):131–42.

Article  Google Scholar 

Zhang X, Guo X, Zong Y, Xu C, Wang J, Zhang B, Liu C, Gong Y, Xue L, Ma L, et al. CTCs detection from intraoperative salvaged blood in RCC-IVC thrombus patients by negative enrichment and iFISH identification: a preliminary study. BMC UROL. 2021;21(1):89.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Costa C, Davila-Ibanez AB. Methodology for the isolation and analysis of CTCs. ADV EXP MED BIOL. 2020;1220:45–59.

Article  CAS  PubMed  Google Scholar 

Tsongalis GJ. Branched DNA technology in molecular diagnostics. AM J CLIN PATHOL. 2006;126(3):448–53.

Article  CAS  PubMed  Google Scholar 

Wu S, Liu S, Liu Z, Huang J, Pu X, Li J, Yang D, Deng H, Yang N, Xu J. Classification of circulating Tumor cells by epithelial-mesenchymal transition markers. PLoS ONE. 2015;10(4):e123976.

Article  Google Scholar 

Ahn KS, O’Brien DR, Kim YH, Kim TS, Yamada H, Park JW, Park SJ, Kim SH, Zhang C, Li H, et al. Associations of serum Tumor biomarkers with Integrated genomic and clinical characteristics of Hepatocellular Carcinoma. LIVER CANCER. 2021;10(6):593–605.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bratu O, Mischianu D, Marcu D, Spinu D, Iorga L, Cherciu A, Balescu I, Bacalbasa N, Diaconu C, Savu C, et al. Renal Tumor biomarkers (review). EXP THER MED. 2021;22(5):1297.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Komarnicki P, Musialkiewicz J, Stanska A, Maciejewski A, Gut P, Mastorakos G, Ruchala M. Circulating Neuroendocrine Tumor Biomarkers: Past, Present and Future. J CLIN MED 2022, 11(19).

Grunnet M, Sorensen JB. Carcinoembryonic antigen (CEA) as Tumor marker in Lung cancer. Lung Cancer. 2012;76(2):138–43.

Article  CAS  PubMed  Google Scholar 

Luo G, Jin K, Deng S, Cheng H, Fan Z, Gong Y, Qian Y, Huang Q, Ni Q, Liu C, et al. Roles of CA19-9 in Pancreatic cancer: Biomarker, predictor and promoter. BBA-REV CANCER. 2021;1875(2):188409.

CAS  Google Scholar 

Lakes J, Arsov C. [PSA screening and molecular markers]. UROLOGE. 2019;58(5):486–93.

Article  CAS  Google Scholar 

Force M, Park G, Chalikonda D, Roth C, Cohen M, Halegoua-DeMarzio D, Hann HW. Alpha-fetoprotein (AFP) and AFP-L3 is most useful in detection of recurrence of Hepatocellular Carcinoma in patients after Tumor ablation and with Low AFP Level. VIRUSES-BASEL 2022, 14(4).

Valerievich YA, Rudiansyah M, Chupradit S, Kadhim MM, Turki JA, Abdelbasset WK, Suksatan W, Mireya RPR, Fakri MY, Abdullaev B, et al. Optical-based biosensor for detection of oncomarker CA 125, recent progress and current status. ANAL BIOCHEM. 2022;655:114750.

Article  Google Scholar 

Debnath P, Huirem RS, Dutta P, Palchaudhuri S. Epithelial-mesenchymal transition and its transcription factors. BIOSCIENCE REP 2022, 42(1).

Manfioletti G, Fedele M. Epithelial-mesenchymal transition (EMT) 2021. INT J MOL SCI 2022, 23(10).

Mittal V. Epithelial mesenchymal transition in Tumor Metastasis. ANNU REV PATHOL-MECH. 2018;13:395–412.

Article  CAS  Google Scholar 

Li J, Liao Y, Ran Y, Wang G, Wu W, Qiu Y, Liu J, Wen N, Jing T, Wang H, et al. Evaluation of sensitivity and specificity of CanPatrol technology for detection of circulating Tumor cells in patients with non-small cell Lung cancer. BMC PULM MED. 2020;20(1):274.

Article  PubMed  PubMed Central  Google Scholar 

Qi LN, Xiang BD, Wu FX, Ye JZ, Zhong JH, Wang YY, Chen YY, Chen ZS, Ma L, Chen J, et al. Circulating Tumor cells undergoing EMT provide a Metric for diagnosis and prognosis of patients with Hepatocellular Carcinoma. CANCER RES. 2018;78(16):4731–44.

Article  CAS  PubMed  Google Scholar 

Cristofanilli M, Budd GT, Ellis MJ, Stopeck A, Matera J, Miller MC, Reuben JM, Doyle GV, Allard WJ, Terstappen LW, et al. Circulating Tumor cells, Disease progression, and survival in metastatic Breast cancer. NEW ENGL J MED. 2004;351(8):781–91.

Article  CAS  PubMed  Google Scholar 

Bork U, Rahbari NN, Scholch S, Reissfelder C, Kahlert C, Buchler MW, Weitz J, Koch M. Circulating tumour cells and outcome in non-metastatic Colorectal cancer: a prospective study. BRIT J CANCER. 2015;112(8):1306–13.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen J, Ye C, Dong J, Cao S, Hu Y, Situ B, Xi X, Qin S, Xu J, Cai Z, et al. Metabolic classification of circulating Tumor cells as a biomarker for Metastasis and prognosis in Breast cancer. J TRANSL MED. 2020;18(1):59.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Markiewicz A, Ksiazkiewicz M, Welnicka-Jaskiewicz M, Seroczynska B, Skokowski J, Szade J, Zaczek AJ. Mesenchymal phenotype of CTC-enriched blood fraction and lymph node Metastasis formation potential. PLoS ONE. 2014;9(4):e93901.

Article  PubMed  PubMed Central  Google Scholar 

Burr R, Gilles C, Thompson EW, Maheswaran S. Epithelial-mesenchymal plasticity in circulating Tumor cells, the precursors of Metastasis. ADV EXP MED BIOL. 2020;1220:11–34.

Article  CAS  PubMed  Google Scholar 

Jie XX, Zhang XY, Xu CJ. Epithelial-to-mesenchymal transition, circulating Tumor cells and cancer Metastasis: mechanisms and clinical applications. Oncotarget. 2017;8(46):81558–71.

Article  PubMed  PubMed Central  Google Scholar 

Vardas V, Politaki E, Pantazaka E, Georgoulias V, Kallergi G. Epithelial-to-mesenchymal transition of Tumor cells: cancer progression and Metastasis. INT J DEV BIOL. 2022;66(1–2–3):277–83.

Article  CAS  PubMed  Google Scholar 

Zhang S, Wu T, Peng X, Liu J, Liu F, Wu S, Liu S, Dong Y, Xie S, Ma S. Mesenchymal phenotype of circulating Tumor cells is associated with distant Metastasis in Breast cancer patients. CANCER MANAG RES. 2017;9:691–700.

Article  CAS  PubMed  PubMed Central  Google Scholar